Search

In this paper, we consider the inverse problem for identifying the initial value problem of the time–space fractional nonlinear diffusion equation. The uniqueness of the solution is proved by taking the fixed point theorem of Banach compression, and the ill-posedness of the problem is analyzed through the exact solution. The quasi-boundary regularization method is chosen to solve the ill-posed problem, and the error estimate between the regularization solution and the exact solution is given. Moreover, several numerical examples are chosen to prove the effectiveness of the quasi-boundary regularization method. Finally, our method can be used to solve high dimensional time–space fractional nonlinear diffusion equation, especially in cylindrical and spherical symmetric regions. [ABSTRACT FROM AUTHOR]

In this paper, the problem we investigate is that the inverse problem of identifying the initial value for fractional pseudo-parabolic equation. This problem is ill-posed, i.e. the solution (if exists) does not depend on the measurable data. We give the estimate of conditional stability under an a-priori bound assumption for exact solution. Two regularization methods are used to solve this problem, and under an a-priori and an a-posteriori selection rule for the regularization parameter, the error estimates for these methods are obtained. Finally, several numerical examples are given to prove the effectiveness of these regularization methods. [ABSTRACT FROM AUTHOR]

The lithology and genesis of a dark grey clastic interlayer first encountered within the deepest potassium-rich salt body in the Simao Basin, southwestern China, were analysed. Analyses of the petrography, mineralogy, and element geochemistry of the layer revealed that (1) the layer contains quartz crystals with gulf corrosion edges and explosion cracks and angular volcanic ash-sized glasses; (2) the main mineral components of the crystal fragments are chlorite, illite, biotite, quartz, anhydrite, gypsum, magnesite, pyrite, molybdenite, clinopyroxene, and zircon; (3) the rare earth element patterns, Zr/TiO2 and Nb/Y diagrams as well as boron content all indicate a volcanic origin for the layer. Based on these observations, the layer is suggested to be an altered tuff associated with various volcanic fragments dominated by chlorite and formed after alteration of a parent tuff in an alkaline, salty, and low-temperature water body. Discovery of the layer indicates that the potash-bearing salt rocks could have taken in volcanic materials during these volcanic activities and provides the possibility of reliable zircon U‒Pb dating to determine the absolute age of the host rock, which is fundamental in studying the genetic mechanism of this deeply buried salt body. [ABSTRACT FROM AUTHOR]

The presence of negative air ions (NAI) is suggested to be a beneficial factor in improving psychological status and used in treating depression as an alternative approach. However, more biological evidence from animal models is needed to ensure the effects of NAI on the mood regulation, through which can facilitate identification of possible underlying mechanisms. In this study, the chronic mild stress (CMS) protocol was used to induce depressive-like behaviors in mice, and the effects of NAI exposure on CMS-induced depression-like behaviors were examined. Thirty-day NAI exposure prevented the CMS-induced depression-like behaviors as shown by the restoration of sucrose preference and reduced immobility time in the tail suspension test. In addition, the elevation of serous corticosterone was present in CMS-treated mice but not existed in those with the NAI exposure. Furthermore, we observed altered ratios of some cytokines secreted by type 1 T helper (Th1) cells and Th2 cells in CMS-treated mice, but it could be restored after NAI exposure. In conclusion, NAI intervention is able to ameliorate CMS-induced depression-like behaviors in mice, and this effect is associated with the alteration of corticosterone and functional rebalance between Th1 and Th2 cells. [ABSTRACT FROM AUTHOR]

Background Neuroendocrine neoplasms (NENs) are a group of diseases that show high heterogeneity but have limited treatment options. This phase I study evaluated the safety and efficacy of sintilimab, anti-PD-1 monoclonal antibody, in treating advanced NENs. Methods We prospectively enrolled patients pathologically diagnosed with NENs after standard treatment failure. Neuroendocrine neoplasms were classified into well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine cancers (NECs). Every patient received sintilimab, and response was assessed every 9 weeks. Results Twenty-four patients with a median age of 57.0 years were enrolled from November 2016 to 2017. The median Ki-67 index was 60%. Five patients had NET, 1 had NET G3, 17 had NEC, and 1 had mixed adenocarcinoma-neuroendocrine carcinoma. The most common primary tumor sites were the pancreas and gastrointestinal tract in 7 and 10 patients, respectively. In phase Ia trial, 2 patients received sintilimab 1 mg/kg every 2 weeks, one received 3 mg/kg every 2 weeks, and 21 patients enrolled in the phase Ib trial received 200 mg every 3 weeks. The objective response rate was 20.8% in all enrolled patients and 27.8% in NEC patients. The median progression-free survival was 2.2 and 2.1 months in patients with NET and NEC, respectively. The median OS was not applicable (NA) and 10.8 months (95% CI, 4.3, NA) with NET and NEC, respectively. The duration of response (DOR) was not reached, with a median follow-up time of 20.7 months. Treatment-related adverse events (TRAE) occurred in 17 (70.8%) patients. The most frequent TRAE was thyroid dysfunction (41.7%), and a grade 3 pulmonary infection occurred in 1 patient. The programmed cell death 1-ligand 1 (PD-L1)-positive (tumor proportion score ≥1%) rate was 18.8% (3 out of 16) and the expression of PD-L1 did not correlate with response. Conclusion Sintilimab was well-tolerated and showed encouraging response in NECs. ClinicalTrials.gov Identifier NCT02937116. [ABSTRACT FROM AUTHOR]

Background: Real‐world safety and effectiveness data for trastuzumab plus chemotherapy treatment of patients with HER2‐positive metastatic gastric cancer (mGC) in China are lacking. Patients and Methods: EVIDENCE was a prospective, multicenter, noninterventional registry study evaluating the safety and effectiveness of trastuzumab in five cohorts of Chinese patients with gastric cancer, stratified by HER2 status and trastuzumab treatment. Effectiveness was analyzed for cohorts I (HER2‐positive, trastuzumab treated), II (HER2‐positive, trastuzumab untreated), and IV (HER2‐negative, trastuzumab untreated); trastuzumab‐related adverse events (AEs) were analyzed for cohort I. Results: Cohorts I, II, and IV included 174, 113, and 422 patients, respectively. Most patients received first‐line chemotherapy (87.6%). Median overall survival (OS1) for first‐line treatment was 22.3, 17.2, and 17.4 months in cohorts I, II, and IV, respectively. After excluding patients who had surgery, respective median OS1 was 19.9, 15.3, and 12.9 months. Respective first‐line progression‐free survival (PFS1) was 8.2, 6.9, and 6.2 months; and respective first‐line response rates (RR) were 51.7%, 18.4%, and 32.8%. Cohort I was significantly favored over cohort II for propensity score–matched first‐line median OS1 (hazard ratio [HR], 0.61), PFS1 (HR, 0.64), and RR (odds ratio, 4.93). Trastuzumab‐related AEs, grade 3–5 AEs, serious AEs, and AEs with a fatal outcome occurred in 23.6%, 3.4%, 2.3%, and 0.6% of cohort I patients, respectively. Conclusion: Safety profiles were consistent with those known for trastuzumab and chemotherapy; trastuzumab treatment improved outcomes. Our study provides real‐world data supporting first‐line trastuzumab plus chemotherapy in Chinese patients with HER2‐positive mGC. Implications for Practice: This prospective, noninterventional registry study aimed to provide safety and effectiveness data for the use of trastuzumab in combination with chemotherapy in Chinese patients with HER2‐positive metastatic gastric cancer (mGC) from the real‐world clinical setting. Trastuzumab plus first‐line chemotherapy was shown to be safe and to improve outcomes when compared with patients treated with chemotherapy alone. Trastuzumab was effective within a range of treatment regimens; subgroup analysis showed that trastuzumab paired most effectively with the XELOX regimen. This study provides real‐world clinical safety and effectiveness data supporting the use of trastuzumab in the treatment of Chinese patients with HER2‐positive mGC. This article reports the results of the EVIDENCE study, which evaluated the effectiveness and safety of trastuzumab in patients with HER2‐positive metastatic gastric cancer in a real‐world setting in China. [ABSTRACT FROM AUTHOR]

Background and aims: Rifaximin has been recommended as a prophylactic drug for hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP). This study aims to explore whether low-dose rifaximin can prevent overall complications and prolong survival in cirrhotic patients. Methods: In this multi-centre randomized open-labelled prospective study, 200 patients with decompensated cirrhosis were randomly assigned at a ratio of 1:1. Patients in rifaximin group were administered 400 mg rifaximin twice daily for 6 months, and all other therapeutic strategies were kept unchanged in both groups as long as possible. The primary efficacy endpoints were the incidence of overall complications and liver transplantation-free survival. The secondary endspoints were the incidence of each major cirrhosis-related complication, as well as the Child–Pugh score and class. Results: The major baseline characteristics were similar in the two groups except for HE. The cumulative incidence and frequency of overall complications were significantly lower in rifaximin group than in the control group (p < 0.001). Though liver transplantation-free survival was not significantly different between the two groups, subgroup analysis showed rifaximin markedly prolonged liver transplantation-free survival in patients with Child–Pugh score ≥ 9 (p = 0.007). Moreover, rifaximin markedly reduced the episodes of ascites exacerbation (p < 0.001), HE (p < 0.001) and gastric variceal bleeding (EGVB, p = 0.031). The incidence of adverse events was similar in the two groups. Conclusion: Low-dose rifaximin significantly decreases the occurrence of overall complications, leading to prolonged survival in patients with advanced stages of cirrhosis in this trail. Further study should be carried out to compare the effect of this low-dose rifaximin with normal dose (1200 mg/day) rifaximin in preventing cirrhosis-related complications. Clinical trial number: NCT02190357 [ABSTRACT FROM AUTHOR]

An observer-based fault-tolerant control method is proposed for a linear system with sensor saturation constraint. Considering the linear system with simultaneous actuator faults and sensor faults, the sensor saturation would bring the output measurement error of the system, which would result in the estimation performance degradation. Firstly, the intermediate estimator is modified to estimate the system states and fault signals at the simultaneous time, and the fault-tolerant controller is designed based on the estimation to compensate the effect of actuator faults effectively. Through Lyapunov stability analysis, the sufficient conditions are obtained to ensure the states of closed-loop system to be uniformly ultimately bounded. The effect of sensor saturation error can be suppressed by adjusting some specified parameters directly without introducing any performance index. Finally, the effectiveness and superiority of the proposed method are verified by a simulation example. [ABSTRACT FROM AUTHOR]

Objective: Lactulose is effective in the treatment and prevention of overt hepatic encephalopathy (OHE), but there are limited data on its use on microbiota in relations to minimal hepatic encephalopathy (MHE) recovery. The present study aimed to assess the efficacy of lactulose in recovery of MHE in aspects of cognitive function, quality of life, and impact on intestinal microbiota. Methods: This multicenter, open‐label randomized controlled trial was conducted in 11 teaching hospitals in China. Participants were randomly allocated on a 2:1 basis to receive lactulose (Gp‐L) or no therapy as control (Gp‐NL) for 60 days. The primary endpoint was the MHE reversal rate. Gut microbiota were compared between MHE patients and healthy volunteers, as well as lactulose‐responders and non‐responders. Results: A total of 98 cirrhotic patients were included in the study, with 31 patients in the Gp‐NL group and 67 patients in the Gp‐L group. At day 60, the MHE reversal rate in Gp‐L (64.18%) was significantly higher than that in Gp‐NL (22.58%) (P =.0002) with a relative risk of 0.46 (95% confidence interval 0.32‐0.67). Number needed to treat was 2.4. Further, there was significantly more improvement in physical functioning in Gp‐L (4.62 ± 6.16) than in Gp‐NL (1.50 ± 5.34) (P =.0212). Proteobacteria was significantly higher in MHE patients compared with healthy volunteers (12.27% vs 4.65%, P < .05). Significant differences were found between lactulose responders and non‐responders in Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria. Conclusions: Treatment with lactulose significantly improves MHE recovery rate, and gut microbiota change in MHE patients can modulate the effectiveness of this therapy. Chinese Clinical Trial Register (ChiCTR) (ID: ChiCTR‐TRC‐12002342). [ABSTRACT FROM AUTHOR]

Based on the production of a carbon nanotube (CNT) assembly, a new technique is developed for preparing CNT/epoxy (EP) composite films with high tensile strength and electrical conductivity. CNTs are synthesized by floating catalyst spray pyrolysis. After self-assembling into a hollow cylindrical assembly, CNTs are drawn and wound on a rotating drum to form a uniform CNT film. EP resin solutions of different concentrations are used to fill into the pores within the film under different pressures and form composite films after hot-press curing. The permeability of the EP resin and thus the interfacial bonding between the CNT and the EP resin are studied by varying the concentration of the EP resin solution and the pressure used for impregnation. Under optimal preparation conditions, the composite film contains CNTs of a high content of 59 wt.%, and shows a high tensile strength of 1.4 GPa and a high electrical conductivity of 1.4×105 S·m−1, 159% and 309% higher than those of the neat CNT film, respectively. [ABSTRACT FROM AUTHOR]

Background: We developed a computer-assisted diagnosis model to evaluate the feasibility of automated classification of intrapapillary capillary loops (IPCLs) to improve the detection of esophageal squamous cell carcinoma (ESCC).Methods: We recruited patients who underwent magnifying endoscopy with narrow-band imaging for evaluation of a suspicious esophageal condition. Case images were evaluated to establish a gold standard IPCL classification according to the endoscopic diagnosis and histological findings. A double-labeling fully convolutional network (FCN) was developed for image segmentation. Diagnostic performance of the model was compared with that of endoscopists grouped according to years of experience (senior > 15 years; mid level 10 - 15 years; junior 5 - 10 years).Results: Of the 1383 lesions in the study, the mean accuracies of IPCL classification were 92.0 %, 82.0 %, and 73.3 %, for the senior, mid level, and junior groups, respectively. The mean diagnostic accuracy of the model was 89.2 % and 93.0 % at the lesion and pixel levels, respectively. The interobserver agreement between the model and the gold standard was substantial (kappa value, 0.719). The accuracy of the model for inflammatory lesions (92.5 %) was superior to that of the mid level (88.1 %) and junior (86.3 %) groups (P < 0.001). For malignant lesions, the accuracy of the model (B1, 87.6 %; B2, 93.9 %) was significantly higher than that of the mid level (B1, 79.1 %; B2, 90.0 %) and junior (B1, 69.2 %; B2, 79.3 %) groups (P < 0.001).Conclusions: Double-labeling FCN automated IPCL recognition was feasible and could facilitate early detection of ESCC. [ABSTRACT FROM AUTHOR]

Background: In a phase III study, sunitinib led to a significant increase in progression-free survival (PFS) versus placebo in patients with pancreatic neuroendocrine tumours (panNETs). This study was a post-marketing commitment to support the phase III data. Methods: In this ongoing, open-label, phase IV trial (NCT01525550), patients with progressive, advanced unresectable/metastatic, well-differentiated panNETs received continuous sunitinib 37.5 mg once daily. Eligibility criteria were similar to those of the phase III study. The primary endpoint was investigator-assessed PFS per Response Evaluation Criteria in Solid Tumours v1.0 (RECIST). Other endpoints included PFS per Choi criteria, overall survival (OS), objective response rate (ORR), and adverse events (AEs). Results: Sixty-one treatment-naive and 45 previously treated patients received sunitinib. By March 19, 2016, 82 (77%) patients had discontinued treatment, mainly due to disease progression. Median treatment duration was 11.7 months. Investigator-assessed median PFS per RECIST (95% confidence interval [CI]) was 13.2 months (10.9–16.7): 13.2 (7.4–16.8) and 13.0 (9.2–20.4) in treatment-naive and previously treated patients, respectively. ORR (95% CI) per RECIST was 24.5% (16.7–33.8) in the total population: 21.3% (11.9–33.7) in treatment-naive and 28.9% (16.4–44.3) in previously treated patients. Median OS, although not yet mature, was 37.8 months (95% CI, 33.0–not estimable). The most common treatment-related AEs were neutropenia (53.8%), diarrhoea (46.2%), and leukopenia (43.4%). Conclusions: This phase IV trial confirms sunitinib as an efficacious and safe treatment option in patients with advanced/metastatic, well-differentiated, unresectable panNETs, and supports the phase III study outcomes. AEs were consistent with the known safety profile of sunitinib. [ABSTRACT FROM AUTHOR]

Introduction: Sunitinib is approved in China for treatment of gastrointestinal stromal tumors (GIST), after disease progression on, or intolerance to, imatinib. However, available data from prospective clinical trials on its efficacy and safety in Chinese patients is limited. Our objective is to determine the efficacy and safety of sunitinib in Chinese patients with imatinib-resistant/intolerant GIST. Methods: An open-label, single-arm, multicenter, phase IV study was performed in Chinese patients with imatinib-resistant/intolerant GIST. Sunitinib was administered orally in 6-week cycles of 4 weeks on-treatment (50 mg once daily) and 2 weeks off-treatment. The primary endpoint was progression-free survival (PFS). Tumors were assessed every 6 weeks for the first 24 weeks and every 12 weeks thereafter. Responses were evaluated according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0. Results: A total of 60 patients were enrolled, of whom 59 were treated with sunitinib. All patients were Asian, and mean age was 55.1 years. Median PFS was 46.4 weeks (95% CI 33.6-53.1). An objective response (complete or partial) was observed in 11/58 (19%) patients. Median overall survival was 111.3 weeks (95% CI 75.4-167.1), median time to tumor progression was 47.3 weeks (95% CI 34.1-59.3), and median time to tumor response was 22.6 weeks (95% CI 10.4-57.3). The most common adverse events included leukopenia, fatigue, hand-foot syndrome, and neutropenia. No new safety concerns were identified. Conclusions: This study confirms that sunitinib is active and well tolerated in Chinese patients with imatinib-resistant/intolerant GIST. ClinicalTrials.gov identifier: NCT00793871. Funding: Pfizer Inc, USA. [ABSTRACT FROM AUTHOR]

The influences of applied magnetic field on the corrosion behavior of Al-3.0 wt%Mg alloy in 3.5 wt% NaCl solution were investigated by electrochemical measurements, scanning electron microscopy (SEM) and energy-dispersive spectroscopy (EDS). Stochastic analysis was applied to investigate the influences of applied magnetic field. The results indicate that the application of horizontal magnetic field of 0.4 T would increase the pitting corrosion potential ( E ), decrease the corrosion current density ( i ), prolong the pit initiation time, slow down the pit generation rate and inhibit the growth of pitting of the tested alloys in 3.5 wt% NaCl solution. The applied magnetic field would also change the mechanism of pit initiation of Al-3.0 wt%Mg alloy from A model (without magnetic field) to A + A model (with magnetic field). The intermediate product Al is the paramagnetic ion that would be influenced by magnetic field sensitively. [ABSTRACT FROM AUTHOR]

Thymic neuroendocrine neoplasms are rare tumours, but their management can often be highly problematic. While previously assumed to be essentially variants of bronchopulmonary (lung) carcinoids, they are generally more aggressive and more difficult to treat. Some 25% are associated with multiple endocrine neoplasia-1, while a higher proportion are associated with the ectopic ACTH syndrome, and occasionally both. We discuss the classification of these tumours, their biology as far as is known, and their clinical, biochemical and imaging features. We also review possible management options and suggest stratagems to optimise their treatment, which even today is far from optimal. [ABSTRACT FROM AUTHOR]

In this study, the authors have developed endoscopic fibre-optic pressure sensor to detect variceal pressure and presented the validation of in vivo and in vitro studies, because the HVPG requires catheterization of hepatic veins, which is invasive and inconvenient. Compared with HVPG, it is better to measure directly the variceal pressure without puncturing the varices in a noninvasive way. [ABSTRACT FROM AUTHOR]

Background and Aims Upper gastrointestinal endoscopy remains the gold standard for diagnosis of esophageal varices. Trans-abdominal ultrasound, as a noninvasive routine examination for the follow-up of cirrhosis patient, is safe, cheap, easy to perform, and plays an important role. In this study, we attempt to design a practical classification analysis model to predict esophageal varices via ultrasound. Methods Compared with endoscopy, the ultrasound qualitative signs (lower esophageal Doppler signals, left gastric vein hepatofugal flow, and paraumbilical vein recanalization) and quantitative parameters (spleen diameter, spleen vein diameter, portal vein diameter, and portal vein velocity) have been evaluated in 286 cirrhosis patients. Results The classification analysis model is designed as that: the patients are defined with esophageal varices high risk, who with any ultrasound qualitative signs or who with spleen diameter greater than 162 mm without qualitative parameters. The sensitivity for detecting esophageal varices is 97.5% and the specificity is 82.6%, while the positive predictive value is 96.7%, negative predictive value is 83.4%, and the omission diagnostic rate is 2.5%. Conclusions This classification analysis model design includes ultrasound qualitative signs and spleen diameter, which can be detected easily via routine ultrasound without other auxiliary. The classification analysis model is useful in detecting esophageal varices, which may be a supplement for predicting of esophageal varices, and reducing the frequency of endoscopy in the follow-up of cirrhosis patients. [ABSTRACT FROM AUTHOR]

Background and Aim: Previous studies have revealed significantly increased levels of plasma and mucosal homocysteine (Hcy) in patients with Crohn's disease (CD); however, whether Hcy is involved in intestinal fibrosis of CD remains unclear. This study aimed to investigate the effects of Hcy on intestinal fibrosis in TNBS/ethanol-induced colitis and to elucidate its potential mechanisms. Methods: Sprague-Dawley rats were divided into 4 groups: normal control, normal + Hcy injection, TNBS model and TNBS model + Hcy injection. Hyperhomocysteinemia was induced by subcutaneous injection of Hcy. DAI, CMDI and HI were calculated to evaluate the severity of colitis. Masson trichrome staining was performed to assess the severity of fibrosis. The plasma and mucosal levels of Hcy were measured by HPLC-FD. The levels of IL-1β, IL-6, TNF-α, TGF-β1, CTGF, MMP-2,9 and collagen I, III in the colon were determined by ELISA, and the mRNA expressions of TGF-β1, MMP-2,9 and TIMP-1 were detected by RT-PCR. Results: Hcy was found to increase the scores of DAI, CMDI and HI; levels of IL-1β, Il-6, TNF-α, TGF-β1, CTGF, MMP-2,9 and collagen I, III; and mRNA expressions of TGF-β1, MMP-2,9 and TIMP-1 in colonic tissue of rats with TNBS/ethanol-induced colitis. Conclusions: Hcy promotes intestinal fibrosis in rats with TNBS/ethanol-induced colitis, the underlying mechanisms of which may be attributed to its effects of increasing inflammatory damage, promoting the expression of profibrogenic cytokines and influencing MMPs/TIMPs balance. [ABSTRACT FROM AUTHOR]

We present an adaptive translation confidence estimation method to predict the human-targeted translation error rate for a document-specific machine translation model. We show the effectiveness of our method that uses features derived from the internal translation decoding process and from the source sentence analysis, in both classification and regression estimate of MT quality. By dynamically training the confidence model for the document-specific MT model, we are able to achieve consistency and prediction quality across multiple documents, demonstrated by the higher correlation coefficient and F scores in finding good sentences. Furthermore, the proposed method is applied to an English-Japanese MT post-editing field study. A strong correlation between our prediction and human selection is observed with a 10 % increase in the productivity of human translators. [ABSTRACT FROM AUTHOR]

Objectives: Acute pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP). Numerous studies have shown that administered nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of acute pancreatitis after ERCP. Little is known, however, about the mechanism of NSAIDs in preventing pancreatitis (PEP). Methods: In this study, we assigned patients to receive a single dose of intramuscular diclofenac 75 mg immediately after ERCP (diclofenac group) or without (control group). The primary outcome measure was the occurrence of PEP. The serum amylase levels were measured before ERCP and at 3 and 24 h post-procedure in all patients. The Lipoxin A4 (LXA4), Resolvin D1 (Rvd1), and Resolvin E1 (RvE1) levels were measured before ERCP, and 3 and 24 h after the procedure in 30 patients from the diclofenac group and 30 patients from the control group. Results: A total of 120 patients were enrolled and completed the follow-up. The overall incidence of PEP was 13.3 % (16/120). It occurred in four of 60 patients (6.67 %) in the diclofenac group and in 12 of 60 patients (20.00 %) in the control group ( p = 0.032). The LxA4, RvD1, and RvE1 levels in the diclofenac group at 3 h after ERCP were significantly increased compared with before ERCP ( p < 0.05). Compared with the control group, the LxA4, RvD1, and RvE1 levels in the diclofenac group at 3 and 24 h after ERCP were significantly increased ( p < 0.05). Conclusions: Intramuscular diclofenac after ERCP can reduce the incidence of PEP. This may be related to the fact that diclofenac can increase the levels of LxA4, RvD1, and RvE1. [ABSTRACT FROM AUTHOR]

Green manuring is a common practice in replenishment of soil organic matter and nutrients in rice paddy field. Owing to the complex interplay of multiple factors, the oxidation–reduction (redox) properties of dissolved organic matter (DOM) from green manure crops are presently not fully understood. In this study, a variety of surrogate parameters were used to evaluate the redox capacity and redox state of DOM derived from Chinese milk vetch (CMV,Astragalus sinicusL.) via microbial decomposition under continuously flooded (CF) and non-flooded (NF) conditions. Additionally, the correlation between the surrogate parameters of CMV–DOM and the kinetic parameters of relevant redox reactions was evaluated in a soil–water system containing CMV–DOM. Results showed that the redox properties of CMV–DOM were substantially different between the fresh and decomposed CMV–DOM treatments. Determination of the surrogate parameters via ultraviolet–visible/Fourier transform infrared absorption spectroscopy and gel permeation chromatography generally provided high-quality data for predicting the redox capacity of CMV–DOM, while the surrogate parameters determined by elemental analysis were suitable for predicting the redox state of CMV–DOM. Depending on the redox capacity and redox state of various moieties/components, NF-decomposed CMV–DOM could easily accelerate soil reduction by shuttling electrons to iron oxides, because it contained more reversible redox-active functional groups (e.g. quinone and hydroquinone pairs) than CF-decomposed CMV–DOM. This work demonstrates that a single index cannot interpret complex changes in multiple factors that jointly determine the redox reactivity of CMV–DOM. Thus, a multi-parametric study is needed for providing comprehensive information on the redox properties of green manure DOM. [ABSTRACT FROM PUBLISHER]

Background. Patients with severe ulcerative colitis (SUC) have a high risk of requiring colectomy or resorting to a second-line treatment. However, neither clinical outcomes nor factors predictive of poor response have been clearly established in the treatment of SUC. Objective. To assess prospectively the effects and predictors of corticosteroids (CS) use in clinical outcomes of SUC during 1 year of follow-up. Material and methods. Consecutive inpatients with SUC, who had been treated with intravenous CS, were enrolled. Patients were monitored by clinical, laboratory, and endoscopic examinations, and the data were recorded for 1 year. Univariate and multivariate analyses were performed at 1 week. Results. There were 22.6% (14/62) nonresponders at 7 days. Several predictors were associated with nonresponse to CS. These included Mayo Score at baseline ( p = 0.007), partial Mayo Score, number of bowel movements, blood presence in stool, abdominal pain, and levels of C-reactive protein (CRP), hemoglobin (Hgb), platelet count (PLT), and erythrocyte sedimentation rate (ESR) on day 3 ( p < 0.05). Multiple logistic regression analysis identified the Partial Mayo Score at day 3 as an independent predictor of outcome ( p = 0.012). A total of 12 patients underwent colectomy within 1 year. The short-term response rates to intravenous cyclosporin (CsA) and infliximab (IFX) in SUC were 71.4% (5/7) and 77.8% (7/9), respectively. Conclusions. Many patients with SUC eventually became refractory to or dependent on CS. The Mayo score and laboratory characteristics were factors useful in predicting short-term outcome of CS treatment. Secondary medical therapy can help avoid emergency surgery. [ABSTRACT FROM AUTHOR]

Purpose: This study aimed to investigate the effect of initial soil pH and organic anion-to-acid ratio on changes in soil pH. Materials and methods: Two soils (Podosol and Tenosol) along with two carboxylic acids (malic and citric acid) and their anions (sodium malate and citrate), commonly found in plant residues, were used in this study. Stock solutions of either malic acid and disodium malate or citric acid and trisodium citrate were added to pre-incubated soils at anion-to-acid ratios of 0:100, 10:90, 25:75, 50:50, 75:25, 90:10, 100:0 and at 0.25 g C kg soil. Soils were adjusted to 80 % field capacity and mixed thoroughly, and three replicates of 50 g of each soil were transferred into individual plastic cores and incubated at 25 °C in the dark for 30 days. Soil pH, respiration, NH, and NO were determined. Results and discussion: Soil pH increased linearly with increasing organic anion-to-acid ratio. The addition of organic anions to soil resulted in net alkalinisation. However, the addition of organic acids immediately decreased soil pH. During subsequent incubation, soil pH increased when the organic anions were decomposed. Alkalinity generation was lower in the Podosol (initial pH 4.5) than in the Tenosol (initial pH 6.2), and was proportional to anion-to-acid ratio across all the treatments. Cumulative CO-C release was approximately three times lower in the Podosol than the Tenosol at day 2 due to lower microbial activity in the low-pH Podosol. Conclusions: Increasing anion-to-acid ratio of organic compounds increased soil pH. Increases in soil pH were mainly attributed to direct chemical reactions and decomposition of organic anions. Low pH decreased the amount of alkalinity generated by addition of organic compounds due to incomplete decomposition of the added compounds. This study implies that organic anion-to-acid ratio in plant residues plays an important role in soil pH change. [ABSTRACT FROM AUTHOR]

Poor prognosis is associated with patients with metastatic colorectal cancer. To seek effective methods, we examine the efficacy and safety of bevacizumab plus FOLFIRI as a second-line chemotherapy in Chinese patients with metastatic colorectal cancer (mCRC). A total of 55 patients with previous failure of oxaliplatin-based chemotherapy were included in this study, from October 2010 to February 2012. All patients received bevacizumab (5 mg/kg) plus FOLFIRI every other week until disease progression or intolerable toxicity occurred. The response rate was 31 %, and the disease-controlled rate was 76.4 %. The median progression-free survival was 6 months, and the median overall survival was 17 months. Adverse events (AEs) related to chemotherapy were mild to moderate. Only the incidence of grade 3–4 neutropenia reached to 25.5 %. The incidence of AEs related to bevacizumab was low. These AEs included grade 3–4 toxicities of hypertension and proteinuria 5.4 and 3.6 %, respectively. Bevacizumab plus FOLFIRI is an effective and safe regimen as a second-line treatment for patients with mCRC in China. [ABSTRACT FROM AUTHOR]

There is growing interest in investigations into soil carbon (C) sequestration, plant nutrients and biological activities in organic farming since it is regarded as a farming system that could contribute to climate mitigation and sustainable agriculture. However, most comparative studies have focused on annual crops or farming systems with crop rotations, and only a few on perennial crops without rotations, e.g. tea (Camellia sinensis(L.) O. Kuntze). In this study, we selected five pairs of tea fields under organic and conventional farming systems in eastern China to study the effect of organic farming on soil C sequestration, plant nutrients and biological activities in tea fields. Soil organic C, total nitrogen (N), phosphorus (P), potassium (K) and magnesium (Mg), available nutrients, microbial biomass, N mineralization and nitrification were compared. Soil pH, organic C and total N contents were higher in organic tea fields. Soil microbial biomass C, N and P, and their ratios in organic C, total N and P, respectively, net N mineralization and nitrification rates were significantly higher in organic fields in most of the comparative pairs of fields. Concentrations of soil organic C and microbial biomass C were higher in the soils with longer periods under organic management. However, inorganic N, available P and K concentrations were generally lower in the organic fields. No significant differences were found in available calcium (Ca), Mg, sodium (Na), iron (Fe), manganese (Mn), copper (Cu) and zinc (Zn) concentrations between the two farming systems. These findings suggest that organic farming could promote soil C sequestration and microbial biomass size and activities in tea fields, but more N-rich organic fertilizers, and natural P and K fertilizers, will be required for sustainable organic tea production in the long term. [ABSTRACT FROM PUBLISHER]

MDPE- g-MAH copolymers were prepared with MDPE (medium density polyethylene) and MAH (maleic anhydride) under different irradiation doses of high-energy electron accelerator, and FTIR spectra confirmed their structure. The effect of the different contents of MDPE- g-MAH copolymers on properties of MDPE/CaCO system is studied intensively. By adding 4 Phr (parts per hundred of resin) MDPE- g-MAH in MDPE/CaCO system under irradiation dose of 0.7 MGy, the tensile strength increases from 16.3 MPa to 19.9 MPa, and elongation at break increases from 437% to 518%. SEM images show the domain size of CaCO in MDPE- g-MAH systems becomes small. Definitely, MDPE- g-MAH copolymer could improve the compatibility of MDPE/CaCO system effectively. [ABSTRACT FROM AUTHOR]

Purpose: The combined contamination of Pb, Zn, Cu, Cd, and As in the soils near lead/zinc mine waste posed a potential threat to the surrounding environment. Mitigation methods are needed to reduce the environmental risk. The aims of this paper were to evaluate the feasibility and efficiency of different forms of phosphates in remediating combined contamination caused by multi-metals and arsenic near the lead/zinc mining tailings. Materials and methods: The tested soil was taken from a clayey illitic thermic typic epiaquepts soil (depth of 0-20 cm) near a lead and zinc mine tailing, located in Shaoxing, Zhejiang Province, China. Four pure chemical reagents, KHPO, Ca(HPO).2HO, Ca(PO), and Ca(PO)OH, were added to the soil in solution form as the trace metal stabilizing additives at a P application rate equivalent to 2,283 mg P/kg-soil and P/Pb molar ratio of 1. Shifts in trace metal speciation were determined using sequential extraction procedures and relative toxicities were evaluated using the standard EPA toxicity characteristic leaching procedure (TCLP). Results and discussion: The addition of KHPO, Ca(PO), Ca(PO)OH, and Ca(HPO).2HO in the contaminated soil at the phosphorus application rate 2,283 mg P/kg-soil reduced Pb concentrations in TCLP extraction solution from 90.47 to 56.05, 83.80, 67.78, and 86.32 mg/kg (38.0, 7.36, 25.1, and 4.59% reduction), respectively. Sequential extraction analysis showed that phosphate treatments caused the transformation of easily available trace metal species to more stable forms. However, TCLP As in the soil increased from its initial value of 0.23 to 2.1, 0.70, 0.67, and 0.77 mg/kg, respectively, for the four treatments. The TCLP leachable As concentration of the KHPO-treated soil was about nine times of that from the untreated soil. Conclusions: The addition of KHPO, Ca(PO), Ca(PO)OH, and Ca(HPO).2HO were effective in reducing water soluble and exchangeable Pb, Zn, Cu, and Cd, and minimizing TCLP-extractable Pb, Zn, and Cu. The sequential extraction test and the TCLP indicate that Ca(PO)OH treatment has a higher potential in immobilizing Pb, Zn, Cu, and Cd, though a slight enhancement of As mobility, comparing with other phosphate treatments. [ABSTRACT FROM AUTHOR]

Background and Purpose: Recently, we invented a computerized endoscopic balloon manometry (CEBM) to measure variceal pressure (VP) in cirrhotic patient. The purpose of this study was to evaluate the reliability and feasibility of this method, and whether this technique provided further information to pharmacological therapy. Patients and Methods: VP measurements were performed in 83 cirrhotic patients and compared with HVPG as well as endoscopic bleeding risk parameters. Furthermore, VP was assessed before and during propranolol therapy in 30 patients without previous bleeding. Results: VP measurements were successful in 96% (83/86) of all patients. Of the 83 patients, the VP correlated closely with the HVPG (P<0.001). The presence of red colour signs and the size of varices were strongly associated with VP. Patients with previous bleeding had higher VP than those who had not yet experienced bleeding. In univariate analysis, the level of VP, the size of varices, and red color signs predicted a higher risk of bleeding. The multiple logistic regression model revealed that VP was the major risk factor for bleeding. In 30 patients receiving propranolol, VP significantly decreased from 21.1±3.5 mmHg before therapy to 18.1±3.3 mmHg after 3 months and to 16.3±4.0 mmHg after 6 months. Comparing the mean decrease in VP with that in hepatic venous pressure gradient (HVPG), the decrease in VP was more obvious than HVPG response to propranolol. Conclusions: This study showed that CEBM is safe and practical to assess VP in cirrhotic patient. It has the potential to be used as a clinical method to assess the risk of variceal bleeding and the effects of pharmacological therapy. Trial registration: Effect of vasoactive drugs on esophageal variceal hemodynamics in patients with portal hypertension. Chinese Clinical Trial Registry –TRC-08000252. [ABSTRACT FROM AUTHOR]

No prediction rule is currently available for advanced colorectal neoplasms, defined as invasive cancer, an adenoma of 10 mm or more, a villous adenoma, or an adenoma with high-grade dysplasia, in average-risk Chinese. In this study between 2006 and 2008, a total of 7,541 average-risk Chinese persons aged 40 years or older who had complete colonoscopy were included. The derivation and validation cohorts consisted of 5,229 and 2,312 persons, respectively. A prediction rule was developed from a logistic regression model and then internally and externally validated. The prediction rule comprised 8 variables (age, sex, smoking, diabetes mellitus, green vegetables, pickled food, fried food, and white meat), with scores ranging from 0 to 14. Among the participants with low-risk (≤3) or high-risk (>3) scores in the validation cohort, the risks of advanced neoplasms were 2.6% and 10.0% (P < 0.001), respectively. If colonoscopy was used only for persons with high risk, 80.3% of persons with advanced neoplasms would be detected while the number of colonoscopies would be reduced by 49.2%. The prediction rule had good discrimination (area under the receiver operating characteristic curve = 0.74, 95% confidence interval: 0.70, 0.78) and calibration (P = 0.77) and, thus, provides accurate risk stratification for advanced neoplasms in average-risk Chinese. [ABSTRACT FROM PUBLISHER]

Aim: We conducted this study to evaluate the role of multidetector computed tomography (MDCT) in diagnosing and differential diagnosis hepatic veno-occlusive disease (HVOD), and as well as assessing the clinical therapeutic effects. Methods: From 2007 to 2010, 10 inpatients with weight increasing, liver pains, ascites, jaundice and history of taking gynura rhizome before hospitalization were scanned with a 64-MDCT. The data were reconstructed every 0.625 mm and reviewed using multiplanar reconstruction (MPR) and liver CT angiography (CTA) on a GE AW4.2 workstation. Patients were re-scanned with MDCT after medication so that the clinical therapeutic effect could be evaluated before the patients discharging from hospital. Results: In 10 HVOD patients, the diagnoses of MDCT were coincident with clinical results. All patients had ascites and pleural fluid, hepatomegaly except the caudate lobe in MDCT. Failure to view hepatic veins in hepatic 3 phase scans, but portal veins and inferior vena cava were unobstructed. In portal-phase, hepatic enhancements were non-uniform. Three patients were incorrectly diagnosed before hospital admission. All patients improved significantly after hepato-protection and supporting therapy. No ascites, hydrothorax, hepatomegaly and obstruction of hepatic veins were observed by MDCT before patients were discharged from hospital. Conclusion: Multidetector computed tomography combined with MPR and liver CTA images are helpful in the diagnosis and differential diagnosis of HVOD and in the evaluation of clinical therapeutic effects. [ABSTRACT FROM AUTHOR]

Background and Aims: Collagen type IV and hyaluronic acid (HA) are the major components of basement membrane and extracellular matrix, respectively. Cathepsin D is an aspartyl lysosomal protease involved in the degradation of the basement membrane and extracellular matrix. The aim of this study is to investigate the clinical significance of collagen type IV and hyaluronic acid in gastric juice and serum in diagnosis of gastric cancer and the degrading effect of cathepsin D on collagen type IV and HA.Methods: Fifty gastric cancer patients were enrolled in our study compared with 41 patients with precancerous lesion and 30 control subjects. Collagen type IV and HA in gastric juice and serum were analyzed by radioimmunoassay. Expression of cathepsin D and collagen type IV in tissue were analyzed by immunohistochemical staining with monoclonal antibodies.Results: The contents of collagen type IV and HA in gastric juice and HA in serum were significantly higher in patients with gastric cancer than those in patients with precancerous lesion and control group (p < 0.05, p < 0.0001). Gastric cancer patients with lymph node metastasis had a higher level of collagen type IV and HA in gastric juice than those in patients without metastasis (p = 0.049, p = 0.043). The expression of cathepsin D had significantly increased in patients with gastric cancer compared to the control group (p < 0.0001). The continuous expression of collagen type IV in basement membrane in gastric cancer group was lower than that in the precancerous lesion group and control group (p < 0.0001).Conclusions: The analysis of collagen type IV and HA in gastric juice and serum may provide a simple aid in diagnosing gastric cancer and evaluating whether metastasis is occurring or not. [ABSTRACT FROM AUTHOR]

Aim:This study investigated the effect of intragastrically administered melatonin on intestinal mucosal permeability induced by diclofenac in mice.Methods:Intestinal mucosal permeability was induced in mice by intragastric administration of diclofenac (2.5 mg/kg). Melatonin was given intragastrically (10 mg/kg) once per day for 3 d after diclofenac administration. The small intestine was examined macroscopically and microscopically for pathologic injury to the intestinal mucosa. Intestinal mucosal permeability was evaluated by Evans blue and FITC-dextran methods. Mitochondrial functional parameters, including mitochondrial membrane potential, mitochondrial ATPase and succinate dehydrogenase (SDH) activity, were assessed. The malondialdehyde (MDA) and myeloperoxidase (MPO) levels were determined from small intestinal mucosal homogenates.Results:As compared with control mice, the permeability, pathologic score, MDA and MPO levels and ulceration of the intestinal mucosa were increased significantly by diclofenac treatment, and a broadened junctional complex and enlarged intercellular space were observed by transmission electron microscopy (TEM). Melatonin treatment significantly reduced the intestinal mucosal permeability, pathologic score, MDA, and MPO levels and ulceration of the intestinal mucosa. By TEM, the small intestine villus morphology and intercellular spaces were nearly normal in melatonin-treated mice. At the level of the mitochondria, melatonin treatment significantly restored the activities of ATPase and SDH.Conclusion:The intestinal damage and increased intestinal permeability induced by diclofenac in mice was limited by melatonin; moreover, melatonin preserved several aspects of mitochondrial function. [ABSTRACT FROM AUTHOR]

The effect of trastuzumab on patients with HER-2/neu (HER2)-positive gastric cancer has been confirmed in a phase III clinical trial (ToGA study). However, the optimized sequence and synergic mechanism of trastuzumab and chemotherapy are not clear. Our study investigated the effects and mechanisms of trastuzumab in combination with 5-Fluorouracil (5-Fu) or cisplatin (DDP) on gastric cancer cell lines. Flow cytometry was used to determine HER2 expression and cell cycle. MTT assay was performed to evaluate cytotoxicity. Western blotting and RT-PCR were used to analyze signaling transduction and mRNA expression. Sequential 5-Fu followed by trastuzumab and trastuzumab plus DDP followed by trastuzumab produced the best inhibitory effects. Inhibition of HER2-PI3K-AKT signal transduction, downregulation of nucleotide excision repair cross-complementation 1 (ERCC1), and interference with cell cycle distribution may elucidate the synergism between trastuzumab and chemotherapy. These results provide some evidence for designing a rational regime when trastuzumab is being considered to be used in patients with gastric cancer. [ABSTRACT FROM AUTHOR]

Obesity is a medical condition in which excess body fat has accumulated to an extent and may have an adverse effect on health, leading to reduced life expectancy, impaired energy homeostasis and increased health problems. The p160 steroid receptor coactivator (SRC) gene family members have been suggested to be involved in energy homeostasis, but the impact of SRC-3 ablation on white and brown adipose tissue needs to be elucidated. In the current study, we collected in vivo data and carried out morphological studies on the effect of SRC-3 deficiency on white adipose tissue (WAT) and brown adipose tissue (BAT). Primary cells were cultured to investigate the differentiation ability of both adipocytes. Western blot was applied to detect the expression of master genes governing adipogenesis and thermogenesis. We observed that SRC-3−/− mice were lean, with reduced WAT and decreased serum leptin levels, mainly due to the smaller white adipocyte size caused by impaired adipogenesis, presented by decreased peroxisome proliferator activated receptor γ (PPARγ) expression. In the BAT, the lipid droplets decreased significantly in SRC-3−/− mice as demonstrated by histological analysis and electron microscopic observation, which could be explained by enhanced thermogenesis. The expression of thermogenic marker gene PPARγ coactivator 1α and uncoupling protein-1 increased in BAT of SRC-3−/− mice, which proved our observations. Collectively, these results demonstrate that SRC-3 plays a key role in adipogenesis and energy expenditure. [ABSTRACT FROM AUTHOR]

A simple and efficient method for selective construction of morphlin-2-one and morphlin-3-one heterocyclic derivatives has been developed from N-substituted aminoethanols and divinyl fumarate. The selectivity of this catalyst-free reaction was easily controlled by different solvents. [ABSTRACT FROM AUTHOR]

The dissolved organic matter (DOM), water soluble organic matter derived from sewage sludge was separated into hydrophobic fraction (Ho) and hydrophilic fraction (Hi). The sorption of DOM and its fractions on soils and the effects of DOM sorption on a nonionic pesticide (atrazine (2-chloro-4-ethylamino-6-isopropylamino-1,3,5-trazine)) distribution between soil and water were investigated using a batch equilibrium technique. The total DOM sorption on soils described by the Langmuir equation reached saturation as the DOMconcentration increased. The sorption of Ho fit the Freundlich model. In contrast, a negative retention evidently occurred as adding Hi at higher level in tested soils. The sorption of Ho dominated the total DOM sorption and the release of soil organic matter (SOM). Effects of DOM on the atrazine sorption by soils were DOM-concentration dependent and dominated by the interaction of atrazine, DOM, and soil solids. Generally, the presence of DOM with lower concentration promoted atrazine sorption on soils, namely the apparent partitioning constant (K^*_d) for atrazine sorption in the presence of DOM was larger than the distribution constant (K_d) without DOM; whereas the presence of DOM with higher concentration inhibited atrazine sorption (i. e., K^*_d

Background. Clinical trials of gefitinib (Iressa, ZD1839) in combination with cytotoxic agents have been carried out or are ongoing in several varieties of tumor. To provide a rationale for future clinical trials, the effects of combining gefitinib with oxaliplatin in different sequences of administration and different dose ratios in two colon cancer cell lines were evaluated. Materials and methods. The colon cancer cell lines HT-29 and LoVo were used. The methods consisted of median effect and combination index analysis, Western blot, mass spectrometry, and a cell death ELISA. Results. In vitro analysis demonstrated that the combination effects of the two agents were sequence-dependent. Changing the sequence of administration from gefitinib first to gefitinib last changed the combination effect from antagonism to synergy. The dose ratio between the two agents affected the combination effects. When equiactive doses of the two agents were used with the sequence gefitinib following oxaliplatin, the greatest level of synergism was obtained (CI=0.6±0.2, P=0.032). Further evaluation revealed that gefitinib significantly inhibited removal of Pt-DNA adducts (P<0.05), providing a potential explanation for the sequence-dependent synergy observed with gefitinib following oxaliplatin. However, this effect was not dose-dependent. Additional studies demonstrated that gefitinib enhanced the effects of oxaliplatin by maintaining oxaliplatin-induced apoptosis, and equiactive dose of gefitinib following oxaliplatin induced prominent enhancement of apoptosis. Conclusions. Oxaliplatin followed by an equiactive relative dose of gefitinib is an appropriate combination for evaluation in colon cancer. [ABSTRACT FROM AUTHOR]

Abstract: The interaction effect of two sulfonylurea herbicides, bensulfuron-methyl (B) and metsulfuron-methyl(M), were tested on microbial biomass C, N, N-mineralization and C/N ratio in a loamy sand soil. The herbicides were applied at various levels of: control (B0M0), 0.01 and 0.01 (B1M1), 0.01 and 0.1 (B1M2), and 0.01 and 1.0 (B1M3) micro g/g soil. Determinations of soil microbial biomass-C, N and N-mineralization contents were carried out at 1, 3, 5, 7, 10, 15, 25 and 45 days after herbicides application. The results showed that the soil microbial biomass-C (C[sub mic]) and microbial biomass-N (N[sub mic]) decreased consistently with the increasing rates of herbicides. The results further indicated that B1M1 and B1M2 caused a significant reduction in C[sub mic] and N[sub mic] within first 10 and 7 days of incubation, respectively, as compared with the control. These reductions in C[sub mic] and N[sub mic] were also significant (P = 0.05) with B1M3 application especially within first 15 days of incubation. A significant reduction in N-mineralization (N-min) was observed with high doses (B1M2, B1M3) of herbicides within first 5 days of incubation, while low rate (B1M1) failed to produce any significant effect. An increase in the soil microbial biomass C:N ratio was also noted. [ABSTRACT FROM AUTHOR]

In order to investigate the predictive value of in vitro MTT assay for directing chemotherapy of breast cancer patients, from 1992 to 1995, 156 advanced breast cancer patients who had evaluable lesions were recruited for a prospective study. Of them 83 had MTT assay before chemotherapthe 73 patients in the MTT sensitive group received chemotherapy according to the result of the MTT assay. The other 10 patients in the MTT resistant group and 73 patients in the control group were given chemotherapy according to clinicians' discretion. The response rate in the MTT sensitive group was 76.7% (56/73). There was statistically significant difference as compared with 0 (0/10) in the MTT resistant group and 43.8% (32/73) in the control group. Between in vitro and in vivo, the overall coincident rate was 79.5%[(56+10)/83]. In the MTT sensitive group, the response rate of the subgroups of lesions and the chemotherapy regiments tended to be higher than that in the control group. Patients in the MTT sensitive group had longer response and survival than those in the control group. However, there was no statistical difference in the median response duration and the median survival between the two groups. Further exploration of in vitro chemosensitivity testing by MTT assay for patients with advanced breast cancer is warranted. [ABSTRACT FROM AUTHOR]

Practical criteria were developed in this paper for the purpose of evaluating chemosensitivity of fresh human breast cancer by the MTT assay. The survival rates at maximum inhibition (Imax %) and the concentrations of drugs which caused fifty percent reduction in absorbance compared to baseline values (IC50) of 175 samples of 10 anti-tumor drugs were evaluated by logistic analyses of the dose-response curves. Distributions of Imax% appeared as normal curves, while those of the IC50 significantly deviated from normal distribution (p < 0.0001). We assessed the in vitro chemosensitivity by comparing the Imax % of each drug on individual samples with the mean Imax % + SD which was obtained from the Imax% of 175 samples. If the individual Imax % > mean Imax % + SD, we thought the tumor sample was resistant to this drug. If the Imax % ≤ mean Imax % + SD, we would compare its IC50 with Q50 which was used as a cutoff point for in vitro chemosensitivity of anti-tumor drugs. The in vitro chemosensitivity could be graded as sensitive (Q1–Q25), intermediate (Q26–Q75), and resistant (Q76–Q100) by means of percentile method. If the individual IC50 ≥ Q76, the tumor sample would be defined as resistant. If the individual IC50 ≤ Q25, it would be defined as sensitive. In the range of Q26–Q75, we used Q50 as a cutoff point between relative sensitivity and relative resistance. Preliminary results showed that the in vitro chemosensitivity to different anti-tumor drugs determined by these criteria were consistent with the clinical response in 83 advanced breast cancer patients. [ABSTRACT FROM AUTHOR]

Feature of wireless and self-organizing makes Ad hoc network very vulnerable to DoS attacks. On the basis of existing research results of DSR-BCA protocol, this paper added a mechanism to deal with DoS attacks. Nodes participate in routing were involved with a verification algorithm of performs routing. When the network data transmission packet loss rate exceeded a preset threshold, the isolation algorithm was used to identify the node which had been DoS attacked and isolated it, so as to maximize the effectiveness of the network nodes. Simulation results show that when Ad hoc network is under DoS attacks, this method has obvious effects on improving two aspects of performance of the average transmission delay and packet delivery ratio. This method can play a very good role in boycotting DoS attacks and enhancing the robustness of the network. [ABSTRACT FROM AUTHOR]

Esophageal squamous cell carcinoma (ESCC) is a highly malignant and deadly tumor. Radiation therapy is one of the primary treatments for locally advanced ESCC. However, the biomarkers for prognosis of definitive radiation remain undefined. Peripheral blood circulating tumor (ct)DNA provides information of tumor genetic alterations and has been confirmed as a potential non-invasive biomarker for several types of cancer. The present study investigated the clinical implications of ctDNA detection in patients with ESCC and receiving definitive radiation therapy. Patients with locally advanced ESCC were retrospectively recruited. Plasma samples were collected before, during and following radiation therapy. Next-generation sequencing was performed to identify somatic mutations in 180 genes. A total of 69 baseline and post-radiation plasma samples were collected from 25 patients. A total of 59 non-silent single nucleotide variants were present in 33 genes. All pre-radiation and 58.3% (14/24) of post-radiation samples had at least one mutation. Patients with lymph node metastases (LNM) exhibited a higher number of pre-radiation mutations compared with those without LNM. The variables, progression-free survival (PFS) and overall survival (OS) of the patients with one baseline mutation were not significantly different compared with that in patients with more than one baseline mutation. Patients with initial ctDNA-positive post-radiation samples exhibited significantly reduced PFS (P=0.047) and OS (P=0.005) compared with that in patients with ctDNA-negative samples. The post-radiation plasma ctDNA status was an independent prognostic factor from univariate and multivariate analyses. Dynamic monitoring of ctDNA during follow-up was examined. The results indicated that ctDNA was a predictive and prognostic marker in patients with ESCC and receiving definitive radiation therapy, which may guide subsequent treatment. [ABSTRACT FROM AUTHOR]

Background. To observe the efficacy, safety, and optimal dosage of recombinant antitumor and antivirus protein (Novaferon) in treating patients with metastatic colorectal cancer (mCRC) who failed at least two prior palliative regimens. Methods. We enrolled 108 patients from May 2011 to December 2012. According to different treatment modalities and therapeutic dosages, the participants were randomly divided into four cohorts at a 2:2:2:1 ratio: (a) 20 µg Novaferon (Genova Biotech, Beijing, People's Republic of China, http://www.genovabiotech.net) injected twice per week, (b) 20 µg Novaferon injected 3 times per week, (c) 40 µg Novaferon injected 3 times per week, or (d) saline injected 3 times per week. The primary endpoint was overall survival. Results. There was no significant difference in overall survival among the four cohorts. The 20-µg dose of Novaferon injected 3 times per week had the highest disease control rate (44.0%) at 6 weeks but without significant differences when compared with placebo (p = .159). Major adverse events with Novaferon were influenza-like symptoms, bone marrow suppression, liver dysfunction, and gastrointestinal discomfort. The level of natural killer cells increased and regulatory T cells decreased significantly after treatment with Novaferon, whereas levels in he placebo group remained the same. Conclusion. Novaferon showed moderate efficacy and was well tolerated in patients with mCRC, especially with the 20-µg dose injected 3 times per week. Furthermore, Novaferon might improve immune function of these patients. [ABSTRACT FROM AUTHOR]